Travaux scientifiques

Doç. Dr. Nargız Majıdova

92 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil
  1. Management of hepatotoxicity associated with CDK4/6 inhibitors and rechallenge strategies in metastatic hormone-positive, HER2-negative breast cancer

    Journal of Cancer Research and Clinical Oncology, 2025

    DOI 10.1007/s00432-025-06336-1 PMID 41014426 4 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  2. Clinical and Demographic Features in Malignant Peritoneal Mesothelioma: Treatment Approaches and Factors Affecting Survival

    Journal of Oncological Sciences, 2025

    DOI 10.37047/jos.galenos.2025.2025-3-18 Texte intégral en libre accèsSource : OpenAlex

  3. 2184P Abscopal effect in patients with metastatic non-small cell lung cancer treated with nivolumab: A multicenter study

    Annals of Oncology, 2025

    DOI 10.1016/j.annonc.2025.08.2803 Texte intégral en libre accèsSource : OpenAlex

  4. 2836P The effect of ribociclib dose reduction on progression-free survival in hormone receptor positive and HER-2 negative metastatic breast cancer: A multicenter study

    Annals of Oncology, 2025

    DOI 10.1016/j.annonc.2025.08.3448 Texte intégral en libre accèsSource : OpenAlex

  5. Efficacy and Safety of the Topotecan–Cyclophosphamide Regimen in Adult Metastatic Ewing Sarcoma: A Large, Multicenter, Real-World Study

    Cancers, 2025

    DOI 10.3390/cancers17030550 PMID 39941915 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  6. Clinicopathological features and treatment outcomes of patients with fibrolamellar hepatocellular carcinoma: a retrospective multicenter study

    Annals of Saudi Medicine, 2025

    DOI 10.5144/0256-4947.2025.249 PMID 40753462 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  7. Impact of Sarcopenia and Osteopenia on Prognosis in Metastatic Biliary Tract Cancer: A Single Center Experience

    Nutrition and Cancer, 2025

    DOI 10.1080/01635581.2025.2496371 PMID 40327413 1 citation (OpenAlex) Source : OpenAlex

  8. Colorectal Cancer Metastasizing to the Thyroid Gland: A Rare and Interesting Case

    Journal of Oncological Sciences, 2025

    DOI 10.37047/jos.galenos.2025.2025-3-11 Texte intégral en libre accèsSource : OpenAlex

  9. Impact of renin angiotensin system inhibitors on survival of patients with metastatic non-small cell lung cancer.

    PubMed Central, 2025

    DOI 10.5144/0256-4947.2025.18 PMID 39929787 6 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  10. Sex-related disparities in outcomes of survival in biliary tract cancer patients

    Journal of Cancer Research and Clinical Oncology, 2025

    DOI 10.1007/s00432-025-06096-y PMID 40016575 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  11. Denovo Metastatic Primary Gastric Ewing Sarcoma/Primitive Neuroectodermal Tumor– 13 Years Follow-up: Case Report and Review of Literature

    Journal of Medicine and Medical Studies, 2025

    DOI 10.51219/jmms/guren-ak/19 Texte intégral en libre accèsSource : OpenAlex

  12. Efficacy of adjuvant capecitabine in residual triple negative breast cancer: a multicenter observational Turkish Oncology Group (TOG) study

    Expert Opinion on Pharmacotherapy, 2024

    DOI 10.1080/14656566.2024.2337261 PMID 38568074 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  13. Kanser Hastalarının Başvurduğu Geleneksel ve Tamamlayıcı Tedaviler - Tıbbi Onkolog Gözü ile Bakış ve Onkolojik İlaçlarla Etkileşim

    Akademisyen Kitabevi eBooks, 2024

    DOI 10.37609/akya.2380 Texte intégral en libre accèsSource : OpenAlex

  14. Efficacy and Safety of Ixabepilone in Metastatic Breast Cancer After Multiple Treatments: Analysis Based on Real-World Data

    Journal of Oncological Sciences, 2024

    DOI 10.37047/jos.2024-102164 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  15. The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing

    Journal of Chemotherapy, 2024

    DOI 10.1080/1120009x.2024.2305066 PMID 38263804 2 citations (Europe PMC) Source : OpenAlex

  16. Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) study

    Journal of Chemotherapy, 2024

    DOI 10.1080/1120009x.2024.2330835 PMID 38497444 7 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  17. Total Neoadjuvant Therapy Versus Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: A Multi-Institutional Real-World Study

    Cancers, 2024

    DOI 10.3390/cancers16183213 PMID 39335184 8 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  18. Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma

    Journal of Chemotherapy, 2024

    DOI 10.1080/1120009x.2024.2403051 PMID 39257075 2 citations (Europe PMC) Source : OpenAlex

  19. The effects of low HER2 expression on survival in patients with metastatic breast cancer treated with CDK 4/6 inhibitors: a multicenter retrospective study

    Breast Cancer Research and Treatment, 2024

    DOI 10.1007/s10549-024-07291-0 PMID 38526689 6 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  20. Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG)

    European Archives of Oto-Rhino-Laryngology, 2024

    DOI 10.1007/s00405-024-08744-4 PMID 38795147 5 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  21. Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World Experience

    Oncology Research and Treatment, 2024

    DOI 10.1159/000537988 PMID 38565096 2 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  22. Bevacizumab versus aflibercept with FOLFIRI after FOLFOX and bevacizumab in RAS mutant metastatic colon cancer a Turkish oncology group study

    Scientific Reports, 2024

    DOI 10.1038/s41598-024-81371-5 PMID 39616250 2 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  23. Prognostic value of systemic inflammatory markers in renal cell carcinoma with isolated lung metastases: A retrospective analysis

    Turkish Journal of Clinics and Laboratory, 2024

    DOI 10.18663/tjcl.1531223 Texte intégral en libre accèsSource : ORCID

  24. Regorafenib Treatment for Recurrent Glioblastoma Beyond Bevacizumab-Based Therapy: A Large, Multicenter, Real-Life Study

    Cancers, 2024

    DOI 10.3390/cancers17010046 PMID 39796675 9 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  25. Which factors help to determine the long-term response to first-line tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: A Turkish multi-centre study

    Biomolecules and Biomedicine, 2024

    DOI 10.17305/bb.2024.10512 PMID 38920621 1 citation (Europe PMC) Texte intégral en libre accèsSource : ORCID

  26. Evaluation of sarcopenia-associated survival in breast cancer with computed tomography-based pectoral muscle area measurements

    Marmara Medical Journal, 2024

    DOI 10.5472/marumj.1484705 1 citation (OpenAlex) Texte intégral en libre accèsSource : ORCID

  27. Balık Yağı / Omega Yağları

    Akademisyen Kitabevi eBooks, 2024

    DOI 10.37609/akya.2380.c13930 Source : ORCID

  28. An evaluation of the clinical and treatment features of renal cell carcinoma

    Journal of Experimental and Clinical Medicine (Turkey), 2024

    DOI 10.52142/omujecm.41.2.12 Source : ORCID

  29. Efficacy of Gemcitabine Plus Nab-paclitaxel in Second-line Treatment of Metastatic Pancreatic Cancer: a Multicenter Retrospective Study in Turkey

    Research Square, 2024

    DOI 10.21203/rs.3.rs-4800776/v1 Texte intégral en libre accèsSource : ORCID

  30. Efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: multicenter study by Turkish Oncology Group

    International Journal of Gynecological Cancer, 2024

    DOI 10.1136/ijgc-2024-005419 PMID 38950923 5 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  31. HER2 exon 20 mutant non-small cell lung cancer with complete remission of intracranial metastases with trastuzumab deruxtecan: A case report

    Anti-Cancer Drugs, 2024

    DOI 10.1097/cad.0000000000001625 PMID 39115060 4 citations (Europe PMC) Source : ORCID

  32. Systemic Inflammation Response Index and Pan-Immune-Inflammation Value: Prognostic Significance in Metastatic Melanoma

    Journal of Oncological Science, 2024

    DOI 10.37047/jos.2024-105164 Texte intégral en libre accèsSource : ORCID

  33. Gustave Roussy Immune Score (GRIm-Score) Predicts Prognosis in Non-Small Cell Lung Cancer Patients Undergoing Nivolumab: A Multicenter Retrospective Study from Turkiye

    International Journal of Hematology and Oncology, 2024

    DOI 10.4999/uhod.247871 Texte intégral en libre accèsSource : OpenAlex

  34. PNI as a Potential Add-On Biomarker to Improve the IMDC Intermediate Prognostic Score

    Journal of Clinical Medicine, 2023

    DOI 10.3390/jcm12196420 PMID 37835062 3 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  35. Prognostic Significance of Mucinous Histology in Metastatic Colorectal Cancer Patients Treated with Regorafenib

    Journal of Oncological Science, 2023

    DOI 10.37047/jos.2022-94250 Texte intégral en libre accèsSource : ORCID

  36. The effects of low HER2 expression on survival in patients with metastatic breast cancer treated with CDK 4/6 inhibitors: A multicentre retrospective study

    Research Square, 2023

    DOI 10.21203/rs.3.rs-3752382/v1 Texte intégral en libre accèsSource : ORCID

  37. The prognostic importance of clinicopathological factors in patients with osteosarcoma who received neoadjuvant therapy; a single center experience

    Research Square, 2023

    DOI 10.21203/rs.3.rs-3610643/v1 Texte intégral en libre accèsSource : ORCID

  38. Evaluation of Predictive and Prognostic Importance of Lung Immune Prognostic Index in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy

    Cureus, 2023

    DOI 10.7759/cureus.40548 PMID 37465788 3 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  39. Impact of Skeletal Muscle Measurements by Chest Computed Tomography on Survival and Postoperative Complications in Patients with Soft Tissue Sarcoma

    Nutrition and Cancer, 2022

    DOI 10.1080/01635581.2022.2063349 PMID 35416100 3 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  40. Is diabetes onset at advanced age a sign of pancreatic cancer?

    Annali Italiani di Chirurgia, 2022

    PMID 36156490 1 citation (OpenAlex) Source : ORCID

  41. Bilateral testicular metastasis of prostate adenocarcinoma: A case report

    Journal of Experimental and Clinical Medicine (Turkey), 2019

    DOI 10.5835/jecm.omu.36.02.006 Texte intégral en libre accèsSource : ORCID

  42. Aggressive skin metastasis in lung cancer,Akciğer kanserinde nadir görülen yaygın cilt metastazı

    Tuberkuloz ve Toraks, 2018

    DOI 10.5578/tt.67010 PMID 30479233 Source : ORCID